RxDoctor Payments Data

Keri Kendall

Physician Assistant · Beatrice, NENPI 1376585364

Payments from drug & device makers

$1,459in general payments, 2019–2025

Across 84 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$467
  • Novo Nordisk$218
  • Novartis$185
  • Pfizer$90
  • Amgen$70
  • Boehringer Ingelheim$61
  • plus $368 from 15 others

What the payments were for

  • Food & beverage$1,459100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,459 in reported general payments places this provider in the 75th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$55,878
JardianceEmpagliflozin61$38,630
XareltoRivaroxaban58$28,963
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$20,217
EntrestoSacubitril/Valsartan32$14,541
TrulicityDulaglutide14$13,741
EliquisApixaban32$13,438
FarxigaDapagliflozin Propanediol26$7,169
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/711$6,333
BrilintaTicagrelor26$5,983
HorizantGabapentin Enacarbil12$5,848
MovantikNaloxegol Oxalate13$5,440
Clobazam21$5,328
Breo ElliptaFluticasone/Vilanterol13$5,146
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,039

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$218$55,87849 claims
Boehringer IngelheimJardiance$61$38,63061 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$13$30,40257 claims
Johnson & JohnsonXarelto$41$28,96358 claims
NovartisEntresto$185$14,54132 claims
Lilly USA, LLCTrulicity$27$13,74114 claims
PfizerEliquis$90$13,43832 claims
AstraZenecaFarxiga, Brilinta$30$13,15152 claims
Astellas Pharma US IncMyrbetriq$31$3,70113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Beatrice

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →